Charles W. Serby COPD Research Fellowship Grant

Charles W. Serby COPD Research Fellowship Grant

Status: ACTIVE
Funder: American Respiratory Care Foundation
Amount: Unspecified amount in in-kind support
Last Updated: April 21, 2025

Summary

The Charles W. Serby COPD Research Fellowship, established in 2002, supports research and education in Chronic Obstructive Pulmonary Disease (COPD). Funded by Boehringer Ingelheim Pharmaceuticals, Inc., this fellowship honors Dr. Charles Serby’s dedication to respiratory research. Awardees, selected from high-quality abstracts presented at the AARC Congress, receive a plaque, airfare, lodging, and registration. Note that this fellowship will not be awarded in 2025 due to ARCF modernization.

Overview

NOTE: This fellowship will not be awarded in 2025 due to the modernization of the ARCF. Mission Statement The American Respiratory Care Foundation is dedicated to promoting respiratory health through the support of research, education, and patient-focused philanthropic activities in respiratory care. Research Fellowships/Abstract Awards All fellows will be selected by ARCF Trustees from researchers having high quality abstracts accepted for presentation at the AARC Congress. Since all accepted abstracts are considered no formal application is required. Under special circumstances determined by the ARCF Board of Trustees, fellowships may be awarded to highly qualified researchers identified through other sources. Each award consists of a plaque, airfare, one night lodging, and registration for the AARC Congress. Charles W. Serby COPD Research Fellowship

Eligibility

You can learn more about this opportunity by visiting the funder's website. All authors must disclose all industry relations for the previous 2 years. It is expected that some authors will have financial and other ties to commercial entities related to products, services, or other aspects of the abstract, either at the time of the submission or previously. We do not consider such potential conflicts of interest to be unethical.However, failure to fully disclose such potential conflicts is unethical.If the study was conducted in an industry laboratory, that must be disclosed.

Ineligibility

Abstracts submitted by industry will not be accepted.Abstracts will not be accepted if ghost written.Abstracts will not be accepted if there is an appearance of industry bias, whether or not conflict of interest has been disclosed.